Genesee Capital Advisors, LLC Merck & Co., Inc. Transaction History

Genesee Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$123.8 - $132.96 $4,456 - $4,786	36 Added 0.46%	7,929 $981,000
Q1 2024 Apr 22, 2024	SELL	$113.24 - $131.95 $8,493 - $9,896	-75 Reduced 0.94%	7,893 $1.04 Million
Q4 2023 Jan 29, 2024	BUY	$100.18 - $109.02 $76,637 - $83,400	765 Added 10.62%	7,968 $868,000
Q3 2023 Oct 24, 2023	SELL	$102.95 - $114.33 $21,001 - $23,323	-204 Reduced 2.75%	7,203 $741,000
Q2 2023 Jul 17, 2023	BUY	$108.61 - $118.38 $804,474 - $876,840	7,407 New	7,407 $854,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Genesee Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Genesee Capital Advisors, LLC with notifications on news.